EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial

Farnoush Fallah iD, Reza Mahdavi iD

Probiotics and Antimicrobial Proteins · 2025

DOI: 10.1007/s12602-025-10460-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Farnoush Fallah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Carnitine, Synbiotics, Obesity, Abdominal, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Research Vice-Chancellor, Tabriz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, a chronic disease with pandemic proportions, is recognized as a major risk factor for cardiometabolic disorders due to its association with atherogenic dyslipidemia, a common characteristic attributed to visceral adiposity in patients with obesity. Atherogenic and visceral-obesity indices have been conceded as surrogate cardiovascular diseases (CVD) indicators surpassing the conventional markers due to stronger predictive power for obesity-induced cardiometabolic risk and CVD mortality rate. Nutraceuticals have been suggested as emerging approaches to counteract obesity-associated cardiometabolic disorders. Considering the evidence addressing the ameliorating effects of either L-carnitine or biotics on metabolic indices, also the reports addressing higher efficacy of concomitant supplementation versus single-therapies, this clinical trial was conducted to assess the effects of L-carnitine + multi-species/multi-strain synbiotic combined supplementation compared to L-carnitine mono-therapy on atherogenic-indices, body composition, visceral obesity, and appetite sensations in 46 metabolically healthy women with obesity, randomly assigned to co-supplementation (L-carnitine-tartrate (2 × 500 mg/dl) + synbiotic (one capsule/day)) or mono-therapy (L-carnitine-tartrate (2 × 500 mg/dl) + maltodextrin (one capsule/day)) groups for 8 weeks. L-carnitine + synbiotic co-supplementation led to a significantly greater reduction in atherogenic-indices including atherogenic-index-of-plasma (AIP), Castelli's-risk-index-I (CRI-I), Castelli's-risk-index-II (CRI-II), atherogenic-coefficient (AC), lipoprotein-combine index (LCI), systolic blood pressure (SBP), fat-mass (FM) weight/percent, visceral-adiposity index (VAI), waste-to-height ratio (WHtR), body-adiposity index (BAI), and appetite sensation scores compared to L-carnitine mono-therapy. L-carnitine + synbiotic combined supplementation was more efficient in improving atherogenic-indices as cardiovascular risk markers, body composition, visceral obesity, and appetite sensations in metabolically healthy women with obesity. Therefore, simultaneous supplementation of L-carnitine + synbiotic might be considered a promising approach to ameliorate cardiometabolic risk factors in healthy individuals with obesity. Further longer period studies are required to confirm these findings. (Iranian Registry of Clinical Trials (IRCT; https://irct.behdasht.gov.ir/trial/28048 ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnitineSynbioticsObesity, AbdominalObesityAppetiteAtherosclerosisHumansFemaleBody CompositionDouble-Blind MethodAdultDietary SupplementsMiddle Aged

Stichwörter der Autor:innen

Appetite sensationsAtherogenic indicesBody compositionL-carnitineMulti-species/Multi-strain synbioticObesity

Substanzen

Carnitine

Autor:innen und Institutionen

  • Student Research Committee, Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nutrition Research Center, Department of Biochemistry and Diet Therapy, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. mahdavir@tbzmed.ac.ir.

ORCID-Profile: Farnoush Fallah, Reza Mahdavi

Förderung

  • Research Vice-Chancellor, Tabriz University of Medical Sciences

Zitieren

APA

Fallah, F., & Mahdavi, R. (2025). Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10460-2

Vancouver

Fallah F, Mahdavi R. Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-025-10460-2

BibTeX
@article{Fallah2025,
  author = {Fallah, Farnoush and Mahdavi, Reza},
  title = {Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  doi = {10.1007/s12602-025-10460-2}
}
Kostenlos starten →